Showing results (451-460 of 1,584) with videos related to
Sort By:
Pageof 159
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 5, 2001
Emergency department management of patients with seizures: a multicenter studyJ S Huff, D L Morris, R U Kothari, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 1984
Regional hyperthermia in the treatment of clinically advanced, deep seated malignancy: results of a pilot study employing an annular array applicatorM D Sapozink, F A Gibbs, K S Gates, et al.Journal of Clinical Pathology|April 1, 1983
Biochemical and histopathological studies on patients with mucopolysaccharidoses, two of whom had been treated by fibroblast transplantationJ Crow, D A Gibbs, W Cozens, et al.Bioorganic & Medicinal Chemistry Letters|June 26, 2016
Exploration of GGTase-I substrate requirements. Part 2: Synthesis and biochemical analysis of novel saturated geranylgeranyl diphosphate analogsKayla J Temple, Elia N Wright, Carol A Fierke, et al.Journal of Psychopharmacology (Oxford, England)|October 8, 2008
Effects of amisulpride on emotional memory using a dual-process model in healthy male volunteersA A Gibbs, K H Naudts, E P Spencer, et al.DNA Sequence : the Journal of DNA Sequencing and Mapping|January 1, 1997
Simultaneous shotgun sequencing of multiple cDNA clonesB Andersson, J Lu, Y Shen, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1985
Electron arc therapy: physical measurement and treatment planning techniquesD D Leavitt, L M Peacock, F A Gibbs, et al.American Journal of Clinical Oncology|April 1, 1986
Regional hyperthermia for clinically advanced deep-seated pelvic malignancyM D Sapozink, F A Gibbs, M J Egger, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Effect of inhibitor depletion on inhibitory potency: tight binding inhibition of CYP3A by clotrimazoleM A Gibbs, K L Kunze, W N Howald, et al.The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferaseRaymond R Mattingly, Richard A Gibbs, Raymond E Menard, et al.Pageof 159